All In Biotech

Free tool

FAERS Monitor: Revuforj

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218944 or its brand name (Revuforj, Revumenib Citrate). Reports on generic versions are filed under their own applications.

Reports

1,031

Serious

628

61% of reports

Hospitalization

308

Death reported

137

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use310
  • nausea172
  • platelet count decreased160
  • product dose omission issue121
  • fatigue110
  • death104
  • vomiting77
  • white blood cell count decreased73
  • pyrexia63
  • haemoglobin decreased51
  • diarrhoea50
  • electrocardiogram qt prolonged49
  • full blood count decreased49
  • thrombocytopenia49
  • differentiation syndrome47

Reports by year received

View as table
YearReports
202410
2025545
2026476

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,128 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
differentiation syndromeSignal471397.01046.260,069
full blood count decreasedSignal4949.737.82,288
platelet count decreasedSignal16030.726.64,579
electrocardiogram qt prolongedSignal4927.821.21,241
white blood cell count decreasedSignal7313.711.0854
haemoglobin decreasedSignal5110.17.8413
thrombocytopeniaSignal498.96.8339
product dose omission issueSignal1218.47.1792
off label useSignal3107.26.61,728
nauseaSignal1724.43.9472
pyrexiaSignal633.72.9124
vomitingSignal773.32.7127
fatigueSignal1102.92.4138
deathSignal1042.52.193
diarrhoea501.61.210

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.